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Repeat Expansions in Leukoencephalopathy 
Adult onset leukoencephalopathy is a heterogeneous condition that often poses a diagnostic 
challenge. After infectious, inflammatory, neoplastic, drug-induced and acquired demyelinating 
disorders have been excluded, the range of potential genetic causes is daunting. Even in this 
era of next-generation sequencing and targeted disease gene panels, the precise genetic 
diagnosis often remains elusive (1,2). In this issue, Okubo and colleagues (3) report that a 
recently identified GGC repeat expansion in NOTCH2NLC (also known as NBPF19) may be a 
relatively common genetic cause of adult onset leukoencephalopathy. This newest repeat 
expansion disease also points to an exciting realization: a cluster of formerly unlinked disorders 
may well constitute a spectrum of age-related neurodegenerative diseases with shared clinical, 
radiographic, neuropathological and molecular features. 
The current report builds on the recent discovery that a GGC repeat expansion in NOTCH2NLC 
(4-7) is the major cause of neuronal intranuclear inclusion disease (NIID), a fatal 
neurodegenerative disorder that also involves peripheral organs. In patients, the diagnosis of 
NIID is made via skin biopsy which reveals the neuropathological hallmark of disease, ubiquitin-
positive intranuclear inclusions that occur in many organs and cell types, including neurons and 
glia of the central and peripheral nervous systems. Before skin biopsy became part of the 
workup, most cases of NIID were only discovered when brain autopsy revealed the 
characteristic neuropathological finding. While NIID often runs in families with an autosomal 
dominant pattern of inheritance, sporadic disease in older persons is not infrequent.  Clinical 
features of NIID vary greatly, with younger onset patients usually presenting with limb weakness 
and older onset patients with dementia (8). Other common findings include neuropathy, 
movement disorder (most often ataxia) and signs of autonomic dysfunction, as well as white 
matter signal abnormalities on brain MRI. In particular, high signal intensity at the 
corticomedullary junction in diffusion-weighted imaging is nearly always found (8). 
Given the white matter involvement in NIID, Okubo and colleagues asked whether this newly 
discovered GCC expansion might also be a cause of adult onset leukoencephalopathy in which 
other genetic causes had been excluded. They evaluated 101 Japanese patients, in 51 of whom 
a custom disease gene panel (1) for causes of leukoencephalopathy had proven negative; the 
remaining 50 newly recruited patients were first assessed by whole exome sequencing, which 
uncovered 7 pathogenic mutations, 6 of which were in the CADASIL disease gene, NOTCH3. (A 
notable incidental finding of this study is that mutations in NOTCH3 can manifest as adult onset 
leukoencephalopathy lacking the typical characteristics of CADASIL.) Remarkably, repeat-
primed PCR analysis in the remaining 94 patients identified the NIID-associated GGC repeat 
expansion in 12 patients, making it perhaps the most common identified cause of adult onset 
leukoencephalopathy.  
What does this collection of a dozen Japanese patients tell us about the characteristics of 
NOTCH2NLC repeat expansion-mediated leukoencephalopathy?  Symptom onset ranged from 
ages 27 to 70 and nearly all patients manifested dementia, decreased deep tendon reflexes, 
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neuropathy and autonomic dysfunction. A minority developed tremor or experienced 
encephalitic episodes. The range of white matter changes detected by MRI varied greatly but 
was always accompanied by ventricular distention, implying a global neurodegenerative 
process.  Skin biopsy was not part of the evaluation, but presumably many or all of the 12 
individuals have NIID. Though it will be important to assess other ethnic populations, the writing 
appears to be on the wall: NOTCH2NLC repeat expansion disease should be considered in the 
differential diagnosis of patients displaying a progressive leukoencephalopathy with cognitive 
impairment, neuropathy and autonomic dysfunction, with or without accompanying movement 
disorder or weakness. 
The list of repeat expansion diseases continues to grow (see table) and the use of new methods 
that can rapidly pinpoint disease-linked simple tandem repeats (9,10) suggests more likely will 
be discovered soon.  As scientists explore the underlying mechanisms of various repeat 
expansion diseases, it has become increasingly clear that they cluster in groups sharing clinical 
and molecular features (11).  Many features of NOTCH2NLC repeat-mediated disease indicate 
that it belongs to one such cluster: neurodegenerative disorders caused by GC-rich repeats 
residing in non-protein coding regions of the respective disease genes. Well-known members of 
this class include fragile X-associated tremor ataxia syndrome (FXTAS) and C9ORF72-
mediated frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS).  Indeed, it was the 
similarity of NIID to FXTAS, including characteristic white matter changes, that led investigators 
(5) to search for repeat expansions in NIID and two similar conditions, oculopharyngeal 
myopathy with leukoencephalopathy (OPML) and oculopharyngodistal myopathy (OPDM). 
State-of-the-art techniques uncovered separate GGC(CGG) repeat expansions in all three 
diseases: in the 5’ UTR of NOTCH2NLC (NIID), 5’ UTR of LRP12 (OPDM) and the 
bidirectionally transcribed long noncoding RNAs LOC642361 and NUTM2B-AS1 (OPML). 
How do noncoding GC-rich repeats in NOTCH2NLC and these other new repeat expansion 
genes cause disease? The inheritance pattern in families with NIID favors a dominant gain-of-
function mechanism. Moreover, the ubiquitin- and p62-positive inclusions found throughout the 
brain in NIID are reminiscent of similar inclusions in FXTAS and C9ORF72 FTD/ALS. Perhaps, 
as in these well-studied diseases (12), repeat associated non-ATG (RAN) translation across the 
GGC repeat generates aggregation-prone RAN proteins.  A second nonexclusive possibility is 
that the repeat expansion sequesters RNA binding proteins, thereby disrupting RNA 
homeostasis. Stay tuned as studies of these newly identified repeat expansions test these 
hypotheses. 
On a final note, white matter disturbances are a frequent finding in progressive dementing 
disorders. While late-life dementia often carries a strong neurovascular component, many 
patients have white matter changes that seem disproportionate to their known cerebrovascular 
risk factors. In the right setting, we already screen for NOTCH3 mutations when the 
radiographic appearance, clinical characteristics and family history suggest CADASIL. For most 
neurologists, however, NIID has not been on their radar. This new report suggests that 
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screening for the NOTCH2NLC repeat expansion will aid in the genetic evaluation of age-
related cognitive impairment accompanied by leukoencephalopathy, especially (but not only) 
when there is a family history of similar disease.  
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Repeat Expansions and Associated Neurologic Disorders 
 
CAG – at least 10 diseases (HD, SBMA, DRPLA, 7 SCAs) 
CTG – myotonic dystrophy type 1, HD-like 2, SCA8, Fuchs corneal dystrophy 
GAA – Friedreich ataxia 
GCC, CCG – FRAXE mental retardation, other fragile sites (GCC, CCG) 
CGG – fragile X syndrome, FXTAS  
GCG –  oculopharyngeal muscular dystrophy (OPMD) 
CGG – OPML, OPDM 
GGC/CGG – NIID, leukoencephalopathy 
CCTG – myotonic dystrophy type 2 
AAGGG – cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) 
TTTCA – benign adult familial myoclonic epilepsies (BAFME 1, 6, and 7) 
ATTCT – SCA 10 
TGGAA – SCA 31 
GGCCTG – SCA 36 
GGGGCC – C9ORF72 FTD/ALS 
CCCCGCCCCGCG – EPM1 myoclonic epilepsy 
 
Microsatellite expansions of the indicated repeat sequences are associated with a wide range of 
neurological diseases. GGC/CGG expansions (bold type) were recently identified in 
NIID/leukoencephalopathy and two similar, rare neurodegenerative diseases, oculopharyngeal 
myopathy with leukoencephalopathy (OPML) and oculopharyngodistal myopathy (OPDM). 
Together with FXTAS, these diseases, which are all caused by noncoding expansions 
consisting only of G and C, constitute a spectrum of related neurodegenerative disorders with 
shared clinical, radiographic and neuropathological features. Abbreviations: DRPLA, 
dentatorubral-pallidoluysian atrophy; FXTAS, fragile X-associated tremor ataxia syndrome; 
FTD/ALS, frontotemporal dementia/amyotrophic lateral sclerosis; HD, Huntington disease; NIID, 
neuronal intranuclear inclusion disease; OPML; SBMA, spinal bulbar muscular atrophy; SCA, 
spinocerebellar ataxia. 
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